Pharmabiz11m
Norgine submits MAA to EMA for eflornithine in high-risk neuroblastoma
Norgine, a uniquely positioned, specialty pharmaceutical and consumer healthcare company, announced that it completed its marketing authorisation application filing to European Medicines Agency (EMA) ...
Pharmabiz29m
No need to get anxious over HMPV virus infection, it is not dangerous like coronavirus: Experts
No need to get anxious over HMPV virus infection, it is not dangerous like coronavirus: Experts: Our Bureau, Chennai Wednesday, January 8, 2025, 16:45 Hrs [IST] Although two cases ...
Pharmabiz59m
Medanta strengthens its Renal Care Institute, appoints leading urologist Dr Sanjay Gogoi as chairman
Medanta strengthens its Renal Care Institute, appoints leading urologist Dr Sanjay Gogoi as chairman: Our Bureau, Mumbai Wednesday, January 8, 2025, 16:15 Hrs [IST] Reinforcing it ...
Pharmabiz1h
US FDA issues draft guidance on including tissue biopsies in clinical trials
US FDA issues draft guidance on including tissue biopsies in clinical trials: Maryland Wednesday, January 8, 2025, 16:00 Hrs [IST] The US Food and Drug Administration (FDA) issued ...
Pharmabiz2h
WuXi Biologics grants exclusive global rights of trispecific t-cell engager to Candid Therapeutics
WuXi Biologics grants exclusive global rights of trispecific t-cell engager to Candid Therapeutics: Shanghai Wednesday, January 8, 2025, 15:00 Hrs [IST] WuXi Biologics, a leading ...
Pharmabiz3h
AIOCD seeks Ministry of Railways to withdraw plans to rope in online pharmacies for home delivery of medicines
AIOCD seeks Ministry of Railways to withdraw plans to rope in online pharmacies for home delivery of medicines: Our Bureau, New Delhi Wednesday, January 8, 2025, 14:10 Hrs [IST] T ...
Pharmabiz3h
US FDA issues new draft guidance aimed to help improve performance of pulse oximeters across skin tones
US FDA issues new draft guidance aimed to help improve performance of pulse oximeters across skin tones: Maryland Wednesday, January 8, 2025, 14:00 Hrs [IST] The US Food and Drug ...
Pharmabiz4h
Arcturus Therapeutics initiates patient dosing in phase 2 multiple ascending dose studies for CF and OTC deficiency
Arcturus Therapeutics initiates patient dosing in phase 2 multiple ascending dose studies for CF and OTC deficiency: San Diego Wednesday, January 8, 2025, 13:00 Hrs [IST] Arcturus ...
Pharmabiz5h
Bayer seeks China NMPA marketing authorization for ARi darolutamide in combo with ADT in patients with metastatic hormone-sensitive prostate cancer
Bayer seeks China NMPA marketing authorization for ARi darolutamide in combo with ADT in patients with metastatic hormone-sensitive prostate cancer: Berlin Wednesday, January 8, 2 ...
Pharmabiz5h
Botanic Healthcare raises Rs. 250 crore to drive global expansion and market leadership
Botanic Healthcare raises Rs. 250 crore to drive global expansion and market leadership: Our Bureau, Bengaluru Wednesday, January 8, 2025, 11:50 Hrs [IST] Botanic Healthcare, Indi ...
Pharmabiz5h
Biocon Biologics completes one-year as an integrated global biosimilars enterprise
Biocon Biologics completes one-year as an integrated global biosimilars enterprise: Our Bureau, Bengaluru Wednesday, January 8, 2025, 11:30 Hrs [IST] Biocon Biologics in its first ...
Pharmabiz6h
US FDA issues comprehensive draft guidance for developers of AI -enabled medical devices
US FDA issues comprehensive draft guidance for developers of AI -enabled medical devices: Maryland Wednesday, January 8, 2025, 11:00 Hrs [IST] The US Food and Drug Administration ...